NCX1 (SLC8A1) Gene

📖 Wiki Page

gene1434 wordssynced 2026-04-02

NCX1 (SLC8A1) Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NCX1 — Sodium Calcium Exchanger 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NCX1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Sodium Calcium Exchanger 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2p23.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/6576" target="_blank">6576</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000155380" target="_blank">ENSG00000155380</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/604527" target="_blank">604527</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprotkb/P32418/entry" target="_blank">P32418</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>938 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~110 kDa</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als), Stroke, Cardiac disease</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Heart, Brain (neurons, astrocytes), Kidney, Smooth muscle</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a>

...

NCX1 (SLC8A1) Gene

NCX1 (SLC8A1) — Sodium Calcium Exchanger 1

Overview

NCX1 (SLC8A1) encodes the sodium-calcium exchanger 1, a crucial bidirectional ion transporter that exchanges 3 Na+ ions for 1 Ca2+ ion across the plasma membrane. It is the predominant NCX isoform in the heart and a critical regulator of calcium homeostasis in [neurons](/entities/neurons) and [astrocytes](/cell-types/astrocytes)[@blaustein2019]. The NCX1 protein plays essential roles in maintaining intracellular calcium balance, regulating neuronal excitability, controlling synaptic plasticity, and determining cell survival outcomes in the face of various pathological insults.

Introduction

The sodium-calcium exchanger family represents one of the most important calcium extrusion mechanisms in eukaryotic cells. Unlike the [Ca2+-ATPase](/proteins/calmodulin) pumps that actively transport calcium against steep concentration gradients, NCX operates as an electrophoretic transporter driven by the transmembrane sodium gradient[@philipson2020]. This fundamental difference gives NCX unique kinetic properties—it can operate in either forward mode (exporting Ca2+ and importing Na+) or reverse mode (importing Ca2+ and exporting Na+), depending on the electrochemical gradients and membrane potential.

In the central nervous system, NCX1 is expressed ubiquitously in neurons and glia, where it serves as a critical buffer against calcium overload conditions that occur during excitotoxicity, ischemia, and neurodegenerative processes. The exchanger's bidirectional nature means that under pathological conditions—particularly during excessive glutamatergic signaling—NCX can paradoxically contribute to calcium influx rather than efflux, exacerbating cellular injury and promoting [neuronal death](/mechanisms/apoptosis)[@annunziato2019].

Gene Structure and Expression

Genomic Organization

The SLC8A1 gene spans approximately 24 kb on chromosome 2p23.3 and contains 8 coding exons. Alternative splicing of the first exon produces multiple transcript variants with distinct tissue distribution patterns. The promoter region contains response elements for several transcription factors including Sp1, AP-1, and NF-κB, allowing dynamic regulation under different physiological and pathological conditions.

Tissue Distribution

NCX1 exhibits broad tissue distribution:

Heart: Highest expression in ventricular myocytes, where it is the primary calcium extrusion pathway during relaxation
Brain: Prominent in cortical [neurons](/entities/neurons), hippocampal pyramidal cells, cerebellar Purkinje cells, and astrocytes
Kidney: Expressed in proximal tubule cells and collecting duct
Smooth muscle: Vascular and gastrointestinal smooth muscle cells
Testis: Spermatogenic cells

Within the brain, NCX1 shows particularly high expression in regions associated with learning and memory, including the [hippocampus](/brain-regions/hippocampus) and prefrontal [cortex](/brain-regions/cortex)[@sirisi2021]. This distribution pattern suggests important roles in synaptic transmission and plasticity.

Protein Structure and Function

Topology

NCX1 is a large transmembrane protein with 11 transmembrane segments organized into two functional domains:

N-terminal transmembrane domain (TM1-TM6): Contains the ion transport pore

C-terminal regulatory domain (TM7-TM11): Contains regulatory sites and the CBD1/CBD2 calcium-binding domains

The protein operates as a dimer, with each monomer capable of independent ion transport, though the dimer architecture provides regulatory cross-talk between subunits.

Transport Mechanism

NCX1 operates through a stochastic single-file transport mechanism:

Forward mode (Ca2+ export): 3 Na+ ions enter, 1 Ca2+ exits

Reverse mode (Ca2+ import): 3 Na+ ions exit, 1 Ca2+ enters

The direction of transport depends on the membrane potential (typically -70 mV in neurons) and the concentration gradients of both Na+ and Ca2+[@pottosin2020]. Under resting conditions, the forward mode predominates, exporting ~10,000 Ca2+ ions per second.

Regulation

NCX1 activity is tightly regulated by several mechanisms:

Intracellular Ca2+: The CBD domains sense cytosolic Ca2+ with micromolar affinity, activating the exchanger in response to elevated calcium

Sodium: High extracellular Na+ can inhibit NCX through an allosteric site

Phosphorylation: PKA and PKC phosphorylation modulate NCX1 activity

PIP2: Phosphatidylinositol 4,5-bisphosphate stimulates NCX1 activity

Protein partners: Interactions with [calmodulin](/proteins/calmodulin), Na+/K+-ATPase, and other proteins modulate function

Role in Neurodegeneration

Alzheimer's Disease

Multiple lines of evidence implicate NCX1 dysfunction in Alzheimer's disease pathogenesis:

Amyloid-β effects: Aβ peptides directly interact with NCX1, reducing its activity and promoting calcium dysregulation[@jeong2018]
Tau pathology: Hyperphosphorylated tau affects NCX1 localization and function
Calcium hypothesis: NCX1 impairment contributes to the calcium dysregulation that drives AD progression[@ullah2018]
Synaptic failure: Loss of NCX1 function in hippocampal neurons contributes to synaptic plasticity deficits

Studies in AD mouse models show that NCX1 expression is reduced in vulnerable brain regions, and restoring NCX1 function can improve cognitive outcomes[@min2017].

Parkinson's Disease

In Parkinson's disease, NCX1 plays complex roles:

Dopaminergic neuron vulnerability: NCX1 reverse mode activation contributes to calcium overload in [substantia nigra](/brain-regions/substantia-nigra) pars compacta neurons
Alpha-synuclein toxicity: NCX1 dysfunction exacerbates alpha-synuclein-induced neuronal death
Mitochondrial dysfunction: NCX1 interactions with mitochondrial calcium handling contribute to energy failure
Therapeutic potential: NCX1 modulators are being explored as neuroprotective agents[@kawasaki2019]

Amyotrophic Lateral Sclerosis (ALS)

NCX1 contributes to motor neuron degeneration in ALS through excitotoxic mechanisms:

Glutamate toxicity: Excessive glutamate stimulation triggers NCX1 reverse mode, importing calcium into motor neurons
Oxidative stress: ROS affects NCX1 function and regulation
Energy failure: Impaired ATP production compromises Na+/K+ gradients, promoting NCX1 reverse mode
Therapeutic targeting: NCX1 inhibitors show promise in ALS models[@friedman2012]

Stroke and Ischemia

NCX1 is a major mediator of post-ischemic neuronal injury:

Energy failure: Loss of ATP during ischemia collapses Na+ gradients
Reverse mode activation: Reduced gradients favor NCX1 reverse mode
Calcium overload: Massive calcium influx through NCX1 contributes to cell death
Neuroprotection: NCX1 blockers reduce infarct size in experimental stroke models[@he2019]

Therapeutic Implications

Current Approaches

| Strategy | Compound | Status | Mechanism |
|----------|----------|--------|-----------|
| NCX1 inhibitors | YM-58483 | Preclinical | Block reverse mode Ca2+ influx |
| Gene therapy | AAV-NCX1 | Preclinical | Overexpression for neuroprotection |
| Natural compounds | Resveratrol | Clinical trials | Upregulate NCX1 expression |

Challenges

Bidirectional nature: Inhibiting NCX1 can impair normal calcium extrusion

Tissue specificity: Cardiac versus neuronal NCX1 selectivity is difficult

Isoform selectivity: Developing isoform-specific inhibitors is challenging

Future Directions

Allosteric modulators: Targeting regulatory domains for more selective modulation
Cell-type specific delivery: Viral vectors for neuron-specific expression
Combination therapy: NCX1 modulation combined with other neuroprotective strategies

Interactome

NCX1 interacts with numerous proteins:

Ion transporters: [Na+/K+-ATPase](/proteins/nak-atpase), L-type Ca2+ channels
Calcium-binding proteins: [Calmodulin](/proteins/calmodulin), S100A1
Signaling proteins: PKA, PKC, PI3K
Cytoskeletal proteins: Ankyrin, Spectrin
Mitochondrial proteins: VDAC, mitochondrial calcium uniporter

Animal Models

Transgenic Models

NCX1 knockout mice: Embryonic lethal due to cardiac defects
Conditional knockout: Neuron-specific deletion shows increased susceptibility to excitotoxicity
Overexpression models: Cardiac and neuronal NCX1 overexpression provides neuroprotection

Phenotypic Findings

Impaired spatial memory in conditional knockouts
Increased infarct size after middle cerebral artery occlusion
Enhanced excitotoxic cell death
Altered synaptic plasticity

Research Directions

isoform-specific modulators: Developing selective NCX1 versus NCX2/NCX3 inhibitors

Blood-brain barrier penetration: Designing CNS-active NCX modulators

Biomarkers: Identifying NCX1 activity indicators for patient stratification

Gene therapy: Vectors for targeted NCX1 delivery to affected neurons

References

[Blaustein MP, et al. Sodium/calcium exchangers in neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/30851863/)

[Philipson KD, et al. The cardiac Na+-Ca2+ exchanger (2020)](https://pubmed.ncbi.nlm.nih.gov/31761742/)

[Annunziato L, et al. The Na+/Ca2+ exchanger in neuronal cells (2019)](https://pubmed.ncbi.nlm.nih.gov/31125604/)

[Pottosin II, et al. On the role of NCX in neuronal excitotoxicity (2020)](https://pubmed.ncbi.nlm.nih.gov/32092378/)

[He Z, et al. The role of Na+/Ca2+ exchanger in brain ischemia (2019)](https://pubmed.ncbi.nlm.nih.gov/30658893/)

[Catalucci D, et al. Physiological and pathological functions of NCX1 (2020)](https://pubmed.ncbi.nlm.nih.gov/32014589/)

[Brustovetsky T, et al. NCX and neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29909068/)

[Mattioni M, et al. Therapeutic potential of NCX modulators (2020)](https://pubmed.ncbi.nlm.nih.gov/32092379/)

[Friedman A, et al. NCX1 in excitotoxicity and ALS (2012)](https://pubmed.ncbi.nlm.nih.gov/22796138/)

[Sirisi S, et al. NCX1 in synaptic plasticity and memory (2021)](https://pubmed.ncbi.nlm.nih.gov/34193671/)

[Jeong SY, et al. NCX1 and amyloid-beta toxicity (2018)](https://pubmed.ncbi.nlm.nih.gov/30593286/)

[Ullah G, et al. Calcium dysregulation and NCX1 in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29507394/)

[Kawasaki H, et al. NCX1 as therapeutic target in PD (2019)](https://pubmed.ncbi.nlm.nih.gov/31102893/)

[Boscia F, et al. NCX1 expression in astrocytes (2016)](https://pubmed.ncbi.nlm.nih.gov/26768053/)

[Min D, et al. NCX1 and calcium mishandling in AD (2017)](https://pubmed.ncbi.nlm.nih.gov/29258462/)

📖 View canonical wiki page →

NCX1 (SLC8A1) Gene

NCX1 (SLC8A1) Gene

NCX1 (SLC8A1) Gene

NCX1 (SLC8A1) — Sodium Calcium Exchanger 1

Overview

Introduction

Gene Structure and Expression

Genomic Organization

Tissue Distribution

Protein Structure and Function

Topology

Transport Mechanism

Regulation

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Stroke and Ischemia

Therapeutic Implications

Current Approaches

Challenges

Future Directions

Interactome

Animal Models

Transgenic Models

Phenotypic Findings

Research Directions

See Also

References